In 167 patients with complete occlusion (>3 cm) of the femoropopliteal artery, percutaneous transluminal laser angioplasty (PTLA) was performed after an unsuccessful attempt at crossing with a guide wire and was immediately followed by balloon dilatation. An Nd-YAG laser and an optical fiber delivery system with a sapphire tip serving as a contact probe were used for PTLA. In 132 of 167 (79%) patients, the occluded segment was successfully reopened.
In 167 patients with complete occlusion (>3 cm) of the femoropopliteal artery, percutaneous transluminal laser angioplasty (PTLA) was performed after an unsuccessful attempt at crossing with a guide wire and was immediately followed by balloon dilatation. An Nd-YAG laser and an optical fiber delivery system with a sapphire tip serving as a contact probe were used for PTLA. In 132 of 167 (79%) patients, the occluded segment was successfully reopened.
Clinical symptoms improved in 126 of 167 (75%) patients. PTLA was unsuccessful in 35 patients, and in 15 of these, injury of the vessel wall occurred. In one patient, surgical drainage of a large hematoma became necessary. All patients in whom recanalization had been achieved were randomized to receive long-term treatment with either phenprocumarol or acetylsalicylic acid (ASA) plus dipyridamole to prevent rethrombosis. At 36 months of follow-up, the cumulative patency rate (CPR) was 63%. A complete reobstruction in 32 patients (24%) and a partial reobstruction in 15 patients (11%) were found angiographically. The CPR after 36 months was significantly lower (p<0.05) in patients younger than 60 years of age (54%) than in patients older than 60 (68%); it was also significantly lower (p<0.05) in patients with reduced peripheral runoff (55%) due to obstructed arteries of the lower leg than in patients with unaffected runoff (73%). The CPR was 65% in recanalized segments shorter than 7 cm and was 62% in recanalized segments longer than 7 cm. In patients treated with ASA plus dipyridamole, the CPR was 60%, and in patients who underwent anticoagulation therapy, the CPR was 65% (NS). The CPR was also significantly lower (p<0.05) in patients who were still smoking during follow-up (62%) than in patients who never smoked or quit smoking (77%). These results suggest that PTLA combined with balloon dilatation is beneficial for the management of patients with chronic peripheral arterial occlusion and provides good long-term patency rates. (Circulation 1991; 83:141-147) Ba alloon angioplasty is a well-established method for recanalizing chronic arterial obstruction.' However, the primary success rate and long-term patency rate after balloon angioplasty are disappointing for complete occlusions longer than 3 cm (26% primary success rate and a 50% 1-year 
Patency
Patency was defined by angiographic criteria. The arterial segment was classified as patent when antegrade flow of the contrast medium was fluoroscopically detected.
Partial Reocclusion
A partial reocclusion was considered when an antegrade flow of the contrast medium was still detected on follow-up angiography, but the diameter of the recanalized segment was restricted by more than 50%.
Clinical Improvement
Clinical improvement was considered to be present when the ankle/arm pressure ratio increased by more than 0.1 and when the clinical condition improved by at least one or two steps in the classifications (from category 3 to 2, category 4 to 3, and category 5 to 3).6
Runoff Circulation
Runoff circulation was defined as reduced when obstruction was detected in the popliteal artery or in more than one calf artery. The runoff circulation was classified as unaffected when no obstruction of the arteries below the recanalized segment could be detected or when obstructions were detectable in one of the three calf arteries.
Statistical Analysis
The x2 tests was used for analyzing primary success rates and reocclusion rates of different subgroups.
The Cox-Mantel test9'0 was used for analysis of cumulative patency rates.
Results

Primary Vascular Reopening Rates
In 26 (14%) of 193 patients, balloon angioplasty alone was performed because a Teflon-coated guide wire could be passed through the occluded segment. These patients were excluded from the study.
The present series includes 167 patients with a femoropopliteal occlusion in whom a primary recanalization rate of 79% (n = 132) was achieved. Ankle/ Reopening by PTLA was prevented either by calcification of the occluded segment (20 patients) or by vessel wall injury by the laser (15 patients). The clinical symptoms in these 35 patients did not worsen during the days after the unsuccessful attempt of PTLA. In 19 of 35 patients in whom PTLA failed, the occluded segment was bypassed surgically as planned; in another patient, the leg had to be amputated because PTLA, as the last possible recanalizing treatment, had failed. The remaining 15 patients were treated intravenously with vasodilating agents.
Side Effects and Complications
Of 167 patients, 103 (62%) reported a sensation of warmth in the treated area. Fifteen of these patients complained of burning pain. These symptoms ceased promptly in all patients when the laser was not activated. In 15 patients (9%), laser treatment caused dissection (n = 9) or perforation (n =6) of the vessel wall, which was detected by arterial dye injection. Vessel injury prevented recanalization in all 15 patients but did not increase the peripheral ischemia and did not necessitate emergency surgery. A curved arterial segment, through which the laser fiber could not follow (n=6), or a calcified plaque, which deflected the laser fiber (n=9), was thought to have caused the vessel wall injury. In one patient, a local hematoma developed at the perforation site compressing the popliteal vein, thus causing peripheral venous stasis. Surgical drainage was performed electively. Twenty-four patients (14%) bled from the arterial puncture site; in 21 patients (13%), only a small hematoma developed; in three (2%), bleeding caused a decrease in the hematocrit level by more than 5%. Heparin had to be discontinued, and reocclusion occurred before randomization. These three patients underwent bypass surgery. Peripheral embolism was precipitated in two patients; subsequent intra-arterial thrombolysis reestablished the patency of the lower-leg arteries in both patients.
Long-term Results
Initially 132 patients with a reopened arterial segment were included in the follow-up study. The mean follow-up period was 14 months (range, 1-36 months). Three patients died from myocardial infarction, and nine patients (7%) dropped out because of side effects. Of these nine, eight received ASA plus dipyridamole and had severe gastrointestinal side effects (3x gastrointestinal bleeding). One (Table 2) . One patient with a reduced runoff after recanalization lost all arteries below the knee joint upon reocclusion and required a below-the-knee amputation. Except for this one patient, reocclusion neither caused worsening of clinical symptoms nor prevented bypass surgery that had originally been planned. The cumulative patency rate after 36 months of follow-up was 63%. The rate of reocclusion did not correlate with the length of the recanalized segment ( Figure 2 ) and with the type of medical treatment (Figure 3 figure. but it correlated with reduced peripheral runoff ( Figure 4) and age of the patient ( Figure 5 ). Reocclusion occurred significantly more often in patients younger than 60 years.
All 15 patients with a partial reocclusion underwent a second balloon dilatation. In eight patients, a completely reoccluded segment was reopened by a second PTLA. Twelve patients underwent femoropopliteal bypass surgery, one patient had a below-the-knee amputation. Despite morphological reocclusion, 11 patients remained clinically improved, thus obviating the need for further recanalizing treatment. (Table 3) . We also speculate that vascular occlusive disease that manifests itself at a younger age runs a more severe and progressive course and is, thus, more difficult to influence by therapeutic manipulations. Reocclusions occurred also more often in patients who had diabetes mellitus (Table 4) . Hyperlipidemia, an important risk factor for peripheral vascular disease, was not considered in further analysis because of its high prevalence (89%) in patients treated by PTLA. Reduced runoff in patients with obstruction of the arteries in the lower leg caused impaired flow after recanalization resulting in a lower patency rate in this group. It is important to note that the long-term patency rate was not influenced by the length of the reopened arterial segment.
Discussion
It must be pointed out that during the period of follow-up, "progression" of the vascular disease only occurred at the site of treatment and beyond. Therefore, a potential effect of the thermal and mechanical damage on recurrent disease must be assumed.
Patients who received balloon dilatation alone in our study were also followed up (n = 26). Ten (38%) reocclusions occurred during a mean follow-up period of 12 months.
However, statistical comparison of long-term results after balloon dilatation alone with PTLA combined with balloon dilatation could not be conducted in this study because the occlusions in the two groups were not comparable. A guide wire could be passed through the occlusion in the balloon dilatation group but not in the PTLA plus balloon dilatation group. Therefore, the occlusions in the two groups may have different physical and chemical properties.
In addition to the primary recanalization by the laser, we think that there might be another advantage for performing PTLA combined with balloon dilatation in completely occluded peripheral arteries. By use of the laser before balloon dilatation, the organized thrombus and the occluding atherosclerotic plaque are partially vaporized by the laser; thus, a smaller amount of occluding material has to be pressed against the vessel wall by the subsequent balloon dilatation than when balloon dilatation alone is performed. This might reduce the incidence of reocclusions. Certainly, we are aware that this hypothesis has to be proved in a controlled study.
In conclusion, PTLA combined with balloon dilatation is a promising technique for reopening complete peripheral arterial occlusions, which cannot be passed through by a guide wire. We have demonstrated that patients suffering from vascular occlusive disease in an early stage with lifestyle-limiting claudication may benefit the most from this technique. We further observed that neither a failed PTLA nor a reocclusion of a primarily recanalized vessel prevented or influenced the outcome of subsequent vascular bypass surgery. Although our results were obtained in an open study, we think that they provide important information on the treatment of patients with complete occlusion of the femoropopliteal artery. Nevertheless, further improvement of the laser technique and the delivery system are necessary to minimize its failure rate.
